Reporter's Take | Anti-trust case spooks Indian generic drug companies

Moneycontrol 2019-05-14

Views 285

Moneycontrol’s Stanford Masters gets in conversation with Viswanath Pilla to know more about Anti-trust case spooks Indian generic drug companies and more…

Show more

Download

Report form

RELATED VIDEOS

Reporter's Take | E-commerce companies’ plan for new FDI policy

play

Reporter's Take | E-commerce companies’ plan for new FDI policy

Reporter's Take | Rising OAIs raises concern for Indian drug cos.

play

Reporter's Take | Rising OAIs raises concern for Indian drug cos.

Reporter's Take | GSP withdrawal may hit US margins of Indian drug cos.

play

Reporter's Take | GSP withdrawal may hit US margins of Indian drug cos.

25 batches of drugs of 18 pharma companies found substandard since January 2018 by BPPI

play

25 batches of drugs of 18 pharma companies found substandard since January 2018 by BPPI

Trade Setup for Tuesday: 5 stocks to keep an eye on June 18

play

Trade Setup for Tuesday: 5 stocks to keep an eye on June 18

End of the road for BSNL, MTNL?

play

End of the road for BSNL, MTNL?

Maruti Suzuki may completely move Brezza production to Toyota’s Bengaluru plant

play

Maruti Suzuki may completely move Brezza production to Toyota’s Bengaluru plant

Explained | How is a budget passed in Parliament?

play

Explained | How is a budget passed in Parliament?

PMC Bank crisis: Your money is safe, RBI assures depositors

play

PMC Bank crisis: Your money is safe, RBI assures depositors

Market Headstart: Nifty likely to open lower; Voltas, Tata Chemicals top sell ideas

play

Market Headstart: Nifty likely to open lower; Voltas, Tata Chemicals top sell ideas

US government wants reciprocity in trade deals: Brian Moynihan, CEO, Bank of America

play

US government wants reciprocity in trade deals: Brian Moynihan, CEO, Bank of America

Trade setup for March 25: Keep an eye on these 5 stocks

play

Trade setup for March 25: Keep an eye on these 5 stocks